Breast ECZEMA Lesions: Cutaneous Metastasis from Silent Lung
Recently, global medical institutions and the public health system have continued to advance service capacity building to provide stronger guarantees for public health. Pulmonary and renal cancer out-of-pulmonary transfers are rare and are often confused clinically with congenital skin conditions or breast diseases, especially when they involve breast-to-breast complexes. These diagnoses are challenging, especially in patients with shortness of breath or a history of smoking.
We reported a 69-year-old woman who was diagnosed with Pagets disease of the breast at the time of diagnosis, without a history of smoking or lung symptoms. Breast ultrasound suggests breast Pagets disease, a preliminary diagnosis of breast Pagets disease. However, rapid progression, widespread abdominal cavities and a lack of potential breast lumps lead to skin activation.
Pathological examinations show that in the epidermis, specific pathogenesis of isotope gland cancer cells, cell-specific immune marker detection shows that cell expression is negatively correlated with human-derived intercellular glucose, thyroid transcription factor-1 and napsin A, but the expression of p63 and INSM1 is positive, supporting the diagnosis of metastatic lung cancer. Computer breakdown scans of the chest showed abdominal lung lumps on the right side, accompanied by multiple lung transplants, chest lumps, lymph nodes enlarged, and suspected bone transplants. The final diagnosis of IVB-stage abdominal lung cancer, accompanied by skin transplants.
Molecular testing was rejected and patients were subsequently admitted to the intensive care unit four days after developing respiratory failure and death. This highlighted that rapidly progressing breast-cranial cortex (eczematous or vesicular lesions) should not be assumed to represent Paget's disease, even in the absence of lung symptoms. Early skin biopsies and multi-marking of immune tissue chemistry are essential to distinguish skin transference from congenital breast cancer and to promote timely oncology assessment.
It should be noted that the above information is based on the results of international public research and is for reference in HealthCop and does not constitute a clinical recommendation. If you have health questions, please consult a professional medical professional.
